Actinium Pharmaceuticals, Inc. (ATNM) stock
ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3081% below fair value
$1.35−0.14 (-9.40%)
Close on Nov 17, 2026Market cap $42.45MP/E 3.8Yield –
Actinium Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Actinium Pharmaceuticals's total assets was $40.16M at Jun 30, 2026. For fiscal 2025 it was $51.78M, down 32.7% from the year before. Over ten years it grew 6.9% a year on average. The highest annual figure on record is $114.19M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $51.78M | -32.7% |
| FY2024 | Dec 31, 2024 | $76.90M | -5.6% |
| FY2023 | Dec 31, 2023 | $81.45M | -28.7% |
| FY2022 | Dec 31, 2022 | $114.19M | +42.1% |
| FY2021 | Dec 31, 2021 | $80.39M | +21.1% |
| FY2020 | Dec 31, 2020 | $66.40M | +469.0% |
| FY2019 | Dec 31, 2019 | $11.67M | -21.6% |
| FY2018 | Dec 31, 2018 | $14.89M | -18.8% |
| FY2017 | Dec 31, 2017 | $18.34M | -18.6% |
| FY2016 | Dec 31, 2016 | $22.53M | -15.3% |
| FY2015 | Dec 31, 2015 | $26.59M | +251.3% |
| FY2014 | Dec 31, 2014 | $7.57M | +31.3% |
| FY2013 | Dec 31, 2013 | $5.77M | -0.4% |
| FY2012 | Dec 31, 2012 | $5.79M | -6.6% |
| FY2011 | Dec 31, 2011 | $6.20M | +4133564.7% |
| FY2010 | Dec 31, 2010 | $150 | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $40.16M | -36.3% |
| Q1 FY2026 | Mar 31, 2026 | $45.44M | -33.8% |
| Q4 FY2025 | Dec 31, 2025 | $51.78M | -32.7% |
| Q3 FY2025 | Sep 30, 2025 | $56.15M | -31.6% |
| Q2 FY2025 | Jun 30, 2025 | $63.02M | -29.9% |
| Q1 FY2025 | Mar 31, 2025 | $68.65M | -22.3% |
| Q4 FY2024 | Dec 31, 2024 | $76.90M | -5.6% |
| Q3 FY2024 | Sep 30, 2024 | $82.11M | -7.7% |
| Q2 FY2024 | Jun 30, 2024 | $89.86M | -9.3% |
| Q1 FY2024 | Mar 31, 2024 | $88.35M | -13.4% |
| Q4 FY2023 | Dec 31, 2023 | $81.45M | -28.7% |
| Q3 FY2023 | Sep 30, 2023 | $88.94M | -23.9% |
| Q2 FY2023 | Jun 30, 2023 | $99.05M | -18.7% |
| Q1 FY2023 | Mar 31, 2023 | $102.03M | +36.8% |
| Q4 FY2022 | Dec 31, 2022 | $114.19M | +42.1% |
| Q3 FY2022 | Sep 30, 2022 | $116.82M | +38.3% |
| Q2 FY2022 | Jun 30, 2022 | $121.80M | +44.2% |
| Q1 FY2022 | Mar 31, 2022 | $74.56M | -0.7% |
| Q4 FY2021 | Dec 31, 2021 | $80.39M | +21.1% |
| Q3 FY2021 | Sep 30, 2021 | $84.48M | +67.2% |
| Q2 FY2021 | Jun 30, 2021 | $84.45M | +50.9% |
| Q1 FY2021 | Mar 31, 2021 | $75.10M | +797.9% |
| Q4 FY2020 | Dec 31, 2020 | $66.40M | +469.0% |
| Q3 FY2020 | Sep 30, 2020 | $50.53M | +209.6% |
| Q2 FY2020 | Jun 30, 2020 | $55.96M | +156.5% |
| Q1 FY2020 | Mar 31, 2020 | $8.36M | -31.6% |
| Q4 FY2019 | Dec 31, 2019 | $11.67M | -21.6% |
| Q3 FY2019 | Sep 30, 2019 | $16.32M | +3.9% |
| Q2 FY2019 | Jun 30, 2019 | $21.82M | -3.4% |
| Q1 FY2019 | Mar 31, 2019 | $12.24M | -56.5% |
| Q4 FY2018 | Dec 31, 2018 | $14.89M | -18.8% |
| Q3 FY2018 | Sep 30, 2018 | $15.70M | -27.7% |
| Q2 FY2018 | Jun 30, 2018 | $22.58M | +74.0% |
| Q1 FY2018 | Mar 31, 2018 | $28.14M | +54.2% |
| Q4 FY2017 | Dec 31, 2017 | $18.34M | -18.6% |
| Q3 FY2017 | Sep 30, 2017 | $21.72M | +25.8% |
| Q2 FY2017 | Jun 30, 2017 | $12.98M | – |
| Q1 FY2017 | Mar 31, 2017 | $18.24M | – |
| Q4 FY2016 | Dec 31, 2016 | $22.53M | – |
| Q3 FY2016 | Sep 30, 2016 | $17.26M | – |
See a number that looks wrong?